Immunomodulators Market size is valued at USD 185.1 billion in 2021 and is expected to reach a value of USD 287.6 million by 2028, growing at a CAGR of 6.5% during the forecast period 2022 to 2028. The global market provides a detailed overview of the immunomodulators market and that can be segmented by product and application. By product, the immunomodulators market has been segmented into immunosuppressants and immunostimulants. The immunosuppressants segment is likely to be the largest and fastest-growing segment in terms of product. The immunosuppressants segment is further segmented into antibodies, calcineurin inhibitors, glucocorticoids, and antimetabolites. Immunostimulants is segregated into vaccines and antibodies. Based on application, the immunomodulators market is segmented into oncology, respiratory, and HIV. Among these, the oncology segment is expected to have the fastest-growing market during the forecast period 2022-2028.
In Feb 2021, PFIZER and BioNTech have begun research to eliminate COVID-19 boosters and new vaccine varieties as part of a bigger development plan.